Acquisition by Albert Bourla of tradable shares of Pfizer subject to Rule 16b-3

CDOZX Fund  USD 41.86  0.37  0.89%   
Slightly above 51% of Columbia Dividend's investor base is interested to short. The analysis of overall sentiment of trading Columbia Dividend Opportunity mutual fund suggests that many investors are impartial at this time. Columbia Dividend's investing sentiment can be driven by a variety of factors including economic data, Columbia Dividend's earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Pfizer Inc Director, Officer: Chairman & Ceo. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at talkmarkets.com
news
  
Pfizer insider trading alert for acquisition of phantom stock units ssp by Albert Bourla, Director, Officer: Chairman & Ceo, on 15th of November 2024. This event was filed by Pfizer Inc with SEC on 2024-11-15. Statement of changes in beneficial ownership - SEC Form 4. Albert Bourla currently serves as group president - vaccines, oncology and consumer healthcare business of Pfizer Inc

Columbia Dividend Fundamental Analysis

We analyze Columbia Dividend's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Columbia Dividend using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Columbia Dividend based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Ten Year Return

Ten Year Return Comparative Analysis

Columbia Dividend is currently under evaluation in ten year return among similar funds. Ten Year Return shows the total annualized return generated from holding a fund for the last 10 years and represents fund's capital appreciation, including dividends losses and capital gains distributions. This return indicator is considered by many investors to be the ultimate measures of fund performance and can reflect the overall performance of the market or market segment it invests in.

Columbia Dividend Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Columbia Dividend mutual fund to make a market-neutral strategy. Peer analysis of Columbia Dividend could also be used in its relative valuation, which is a method of valuing Columbia Dividend by comparing valuation metrics with similar companies.

Other Information on Investing in Columbia Mutual Fund

Columbia Dividend financial ratios help investors to determine whether Columbia Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Columbia with respect to the benefits of owning Columbia Dividend security.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing